Results 41 to 50 of about 26,298 (212)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma

open access: yesCase Reports in Oncology, 2014
Little information is available about the usefulness of concurrent chemoradiotherapy for locally advanced thymic carcinoma due to a rare anterior mediastinal tumor.
Toshirou Fukushima   +5 more
doaj   +1 more source

Adjuvant Therapy for Thymic Carcinoma--A Decade of Experience in a Taiwan National Teaching Hospital. [PDF]

open access: yesPLoS ONE, 2016
Thymic carcinomas are rare tumors for which surgical resection is the first treatment of choice. The role of adjuvant treatment after surgery is unknown because of limited available data.
Yen-Han Tseng   +8 more
doaj   +1 more source

Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis [PDF]

open access: yes, 2015
BACKGROUND AND PURPOSE: The World Health Organization (WHO) has classified thymic carcinoma and other thymomas (types A, AB, and B) as different neoplasms.
김세훈
core   +1 more source

Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma [PDF]

open access: yes, 2021
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and pathology differ from that of benign thymoma, presenting a poorer prognosis.
Yusuke Okuma, Rui Kitadai
core   +1 more source

Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma

open access: yesThoracic Cancer, 2023
Thymic carcinoma is a highly malignant tumor and treatment options are limited. Lenvatinib, a novel multitargeted kinase inhibitor, has recently been approved for the treatment of unresectable thymic carcinoma.
Masatoshi Shimura   +10 more
doaj   +1 more source

Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report

open access: yesThoracic Cancer, 2022
Advanced thymic carcinomas have limited treatment options. Recently, lenvatinib was approved for advanced thymic carcinoma treatment. However, the clinical benefit of lenvatinib re‐administration in patients with advanced thymic carcinoma who developed ...
Yuto Terashima   +3 more
doaj   +1 more source

THYMIC CARCINOMA - A RARE CASE REPORT [PDF]

open access: yes, 2018
Introduction. Thymic carcinoma is a rare, invasive mediastinal neoplasm with a tendency to metastasize. They constitute a heterogeneous group of tumors that present differently in terms of both behavior and  prognosis. Case report.
Arnav Kr Roychoudhury   +2 more
core   +1 more source

Thymic Carcinoma which Developed in a Thymic Cyst.

open access: yesInternal Medicine, 1996
Thymic carcinoma was found in a thymic cyst in a 60-year-old woman who was admitted to our hospital due to cough and pain in her right chest. Chest X-ray showed a huge shadow in the right mediastinum. Chest CT scan showed a cystic tumor with a solid mass. An operation revealed a solid tumor in the thymic cyst.
YAMASHITA, Shu-ichi   +5 more
openaire   +3 more sources

Thymic Carcinoma Associated with Cerebellar Degeneration [PDF]

open access: yes, 2017
We present the case of a 57-year-old man with ataxia and clinical and radiological features of cerebellar degeneration. A computed tomography showed a mediastinal mass. The patient was diagnosed of thymic carcinoma. paraneoplastic cerebellar degeneration
Rodríguez Galdeano, Mónica   +7 more
core   +1 more source

Novel biomarkers for thymic carcinoma [PDF]

open access: yes, 2019
Thymic carcinoma (TC), the rarer among Thymic Epithelial Tumors (TET), occur with an incidence rate of 0.2-0.5/million/yr. Difficulties in the evaluation of molecular aspects derive from the extreme rarity of these tumors.
Casini, B.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy